Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 106 to 120 of 203 results for dementia

  1. New pharmaceutical treatments for non-Alzheimer dementias [ID380]

    Discontinued Reference number: GID-TAG369

    Technology appraisal guidance
    Discontinued

  2. Develop case identification tools for common mental health problems:- Develop or adapt reliable and valid tools for the case identification of common mental health problems in people with learning disabilities, for routine use in primary care, social care and education settings.

    common mental health problems such as depression and anxiety disorders, or dementia in Down's syndrome. As a result, the identification...

    Research recommendation
    Published
    17 October 2016

  3. Aducanumab for treating mild cognitive impairment and mild dementia caused by Alzheimer's disease [ID3763]

    Discontinued Reference number: GID-TA10739

    Technology appraisal guidance
    Discontinued

  4. What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for improving long-term health outcomes for people with subclinical hyperthyroidism?

    associated with an increased risk of atrial fibrillation, osteoporosis, dementia, and death, including death from cardiovascular...

    Research recommendation
    Published
    10 February 2020

  5. Physical activity: for NHS staff, patients and carers (QS84)

    This quality standard covers encouraging physical activity in people of all ages who are in contact with the NHS, including staff, patients and carers. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    25 March 2015
    View quality statements

    Sections for QS84

  6. Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges (NG11)

    This guideline covers interventions and support for children, young people and adults with a learning disability and behaviour that challenges. It highlights the importance of understanding the cause of behaviour that challenges, and performing thorough assessments so that steps can be taken to help people change their behaviour and improve their quality of life. The guideline also covers support and intervention for family members or carers.

    NICE guideline
    Published
    29 May 2015
    View recommendations

    Sections for NG11

  7. Cardiovascular disease. Patient decision aid on should I take a statin?

    whether statins might cause dementia. There is no good evidence that statins do this (but some people who take statins will get...

  8. Insertion of a magnetic bead band for faecal incontinence (HTG336)

    Evidence-based recommendations on insertion of a magnetic-bead band for faecal incontinence. This involves placing a ring of magnetic beads into a tunnel made around the anus to prevent incontinence.

    HealthTech guidance
    Published
    27 March 2014
    View recommendations

    Sections for HTG336

  9. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  10. Psychotic symptoms (hallucinations and delusions):- What is the effectiveness of rivastigmine compared with atypical antipsychotic drugs for treating psychotic symptoms (particularly hallucinations and delusions) associated with Parkinson's disease?

    some effectiveness in improving behavioural symptoms in people with Parkinson's disease dementia. At present, no evidence exists to...

    Research recommendation
    Published
    15 October 2018

  11. What is the effectiveness of statin therapy in older people?

    statins in preventing or promoting other chronic diseases of ageing such as dementia, Parkinson's disease, or age-related macular...

    Research recommendation
    Published
    9 June 2015

  12. Daily mouth care for residents:- Does the delivery of a daily mouth care regimen in care homes maintain or improve adult residents' oral health-related quality of life?

    adults with poor physical health, or a short life expectancy, or adults with dementia. It is important to understand the impact of oral...

    Research recommendation
    Published
    24 August 2016

  13. Does early review of service provision and referral to additional specialist palliative care services improve outcomes for adults with progressive non-cancer disease thought to be approaching the end of their life?

    with life-limiting neurological disease, such as motor neurone disease or dementia. Such patients are typically referred very late to...

    Research recommendation
    Published
    18 November 2019

  14. Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with motor neurone disease (MND) on clinical practice, the person and their family and carers? Does repeated assessment provide more benefit than assessment at a single point at diagnosis?

    studies demonstrate that up to 15% of people with MND have frontotemporal dementia. A further third of people with MND have changes in...

    Research recommendation
    Published
    21 March 2016

  15. Effectiveness and costs of oral health interventions for care home residents:- How effective and cost effective are oral health interventions in care homes including suitableperson-centred outcome measures?

    differential effects on sub-populations in care homes. This includes: people with dementia, people in poor physical health, those with a...

    Research recommendation
    Published
    24 August 2016